ELAN Q3 2023 Earnings — Elanco Animal Health Incorporated Revenue & Financial Results | Market Cap Arena

ELANElanco Animal Health Incorporated

$12B

Q3 2023 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1.1B+4.1% YoY

Gross Profit

$441M41.3% margin

Operating Income

$42M3.9% margin

Net Income

-$1.1B-102.6% margin

EPS (Diluted)

$-2.22

QoQ Revenue Growth

+1.0%

Cash Flow

Operating Cash Flow

$198M

Free Cash Flow

$165M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$14.3B

Total Liabilities

$8.2B

Stockholders' Equity

$6.1B

Cash & Equivalents

$369M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.1B	$1.0B	+4.1%
Gross Profit	$441M	$426M	+3.5%
Operating Income	$42M	$50M	-16.0%
Net Income	-$1.1B	-$65M	-1586.2%

Revenue Segments

Farm Animal

$561M35%

Pet Health

$495M31%

Cattle

$242M15%

Poultry

$184M12%

Swine

$93M6%

Contract Manufacturing

$12M1%

Geographic Segments

Non-US

$589M55%

UNITED STATES

$479M45%